CN87105764A - 2-氨基-4-甲膦酰丁酸抗性基因及其应用 - Google Patents
2-氨基-4-甲膦酰丁酸抗性基因及其应用 Download PDFInfo
- Publication number
- CN87105764A CN87105764A CN87105764.6A CN87105764A CN87105764A CN 87105764 A CN87105764 A CN 87105764A CN 87105764 A CN87105764 A CN 87105764A CN 87105764 A CN87105764 A CN 87105764A
- Authority
- CN
- China
- Prior art keywords
- ptc
- resistance
- ptt
- fragment
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 25
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 title 2
- 239000012634 fragment Substances 0.000 claims abstract description 18
- 241000187191 Streptomyces viridochromogenes Species 0.000 claims abstract description 3
- 241001655322 Streptomycetales Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims description 3
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000003550 marker Substances 0.000 abstract description 2
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 13
- 239000000203 mixture Substances 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 102000005396 glutamine synthetase Human genes 0.000 description 4
- 108020002326 glutamine synthetase Proteins 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 241000123650 Botrytis cinerea Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- YZHUMGUJCQRKBT-UHFFFAOYSA-M sodium chlorate Chemical compound [Na+].[O-]Cl(=O)=O YZHUMGUJCQRKBT-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229930188070 thiostrepton Natural products 0.000 description 1
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 1
- 229940063214 thiostrepton Drugs 0.000 description 1
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/007—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
- C12N15/8277—Phosphinotricin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Catalysts (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
通过在绿色产色链霉菌DSM4112中选择2-氨基-4-甲膦酰-丙氨酰-丙氨酸(PTT)抗性而产生PTT抗性的选择体。用BamHI酶切这些选择体的总DNA得到携有Phosphinothricin(PTC)抗性基因的DNA片段,克隆4.0Kb大小的片段并选择PTT抗性。此基因适用于生产PTC抗性的植物,以及作为抗性标记用于L型外消旋PTC的选择性N-乙酰化作用。
Description
Phosphinothricin(PTC,2-氨基-4-甲膦酰丁酸)是谷氨酰胺合成酶的抑制剂。PTC是抗生素2-氨基-4-甲膦酰-丙氨酰-丙氨酸的“结构单位”。此三肽(PTT)具有抗革兰氏阳性和革兰氏阴性细菌以及抗真菌灰葡萄孢(Botrytis cinerea)的活性(Bayer等人,Helv.Chim.Acta 55∶224,1972)。PTT是由绿色产色链霉菌(Streptomyces viridochromogenes)Tu 494菌株(DSM40736,DSM4112)产生的。
德国专利2,717,440号公开了PTC可起全除莠剂(total herbicide)的作用。已公开的PCT申请WO86/02097号描述了植物对PTC的抗性是归因于谷氨酰胺合成酶的过量生成。这种类型的过量生成(如从基因扩增所导致的)易遭受不稳定的风险。因此,这样一种不稳定性将带来谷氨酰胺合成酶过量生成的下降,将致使重新出现PTC的竞争性抑制作用。
与之相反,在权利要求中所限定的本发明涉及一种PTC抗性基因及其在生产PTC抗性植物中的应用。此外,该基因还可作为抗性标记使用。而且,该基因可适于L型外消旋PTC的选择性N-乙酰化作用。
本发明的PTC抗性基因能由下述步骤得到:用BamHⅠ酶切以PTT抗性选择出来的绿色产色链霉菌DSM4112菌株的总DNA,克隆大小为4.0Kb的片段,然后选择PTT抗性。限制性图谱(图1)详细描绘了该4.0Kb片段的特征。
对该4Kb片段部分进行克隆实验,以更精确地确定编码区的位置。此实验结果表明,抗性基因位于1.6Kb的SstⅡ-SstⅠ片段上(图1中位置0.55至2.15)。用BglⅡ消化产生0.8Kb大小的片段,此片段掺入质粒中并转化变铅青链霉菌(S.lividans)后赋予PTT抗性。此抗性是由PTC的N-乙酰化产生的。
对此0.8Kb片段进行Maxam和Gilbert序列分析得到DAN序列Ⅰ(见附页)。抗性基因的位置可从这一序列的开放读码(open reading frame)确定(从位置258起)。此基因读码终点位于图示的倒数第二个核苷酸(位置806),即最后一个核苷酸(位置807)是终止密码子的第一个核苷酸。
用下加线条强调标明了DNA序列Ⅰ中的Shine-Dalgarno序列,作为起始密码子的GTG也用线条标出。而且,顶部线条标出了确定的读码。
DNA序列Ⅱ显示已确定了序列的基因中的限制性切点。没有标出切断此序列六次以上的酶。
抗生素PTT由细菌摄取并被降解为PTC。后者也抑制细菌中的谷氨酰胺合成酶,致使细菌因缺乏谷氨酰胺而死亡。因此,产生PTT的细菌应当具有保护自身不受PTT影响的机理,也就是说,防止再度摄取已生产的PTT,或者对已降解的产物PTC进行修饰。但令人吃惊的是,PTT生产菌绿色产色链霉菌DSM4112对其自身的抗生素敏感。但出人意料地证实,通过选择PTT抗性,有可能以10-5的极高频率发现抗PTT的选择体,而且,此选择体还能抑制相邻菌落的本底生长。
通过分离此DNA、用BamHⅠ切断并连接到链霉菌载体中建立了这些选择体DNA的基因库。将连接混合物转化到市售的变铅青链霉菌TK23菌株中,每1μg连接混合物产生大约5000至10000个含有大约1至5Kb插入段的转化体。在这些转化体中有PTT抗性变铅青链霉菌株。有可能通过质粒分离并重新转化到变铅青链霉菌中,证明该抗性是由质粒编码的。负责此抗性的基因位于4Kb BamHⅠ片段上(图1)。编码区位于0.8Kb BglⅡ片段上。BamHⅠ片段中不含下列酶的切点:ClaⅠ、EcoRⅠ、EcoRⅤ、HindⅢ、HpaⅠ、KpnⅠ、PvuⅠ、PvuⅡ和XhoⅠ。
将抗性基因的限制性图谱(还没有详细确定其特征)与吸水链霉菌(S.hygroscopicus)FERM BP-130/ATCC21705(欧洲专利申请,公开号0,173,327,图7)相比较表明,本发明的抗性基因不同于已知基因,其为寻找PTT生物合成基因过程中发现的。
一方面使绿色产色链霉菌DSM4112和变铅青链霉菌TK23的细胞提取物与PTC和乙酰辅酶A保温,另一方面使PTT抗性的绿色产色链霉菌选择体和携有质粒的变铅青链霉菌转化体与PTC和乙酰辅酶A保温,有可能表明后面的细胞将具有乙酰化活性。层析分析表明乙酰化发生在氨基上。
由于大肠杆菌中也已发现了PTT抗性,而且抗性机理也在革兰氏阴性细菌中起作用,因此,有可能基于运送现象排除抗性。这样,与植物启动子偶联并使用合适的载体后,本发明的抗性基因可转化到植物中,从而可产生PTC抗性植物。
PTC的N-乙酰化还可用于合成的D,L-PTC的外消旋体拆开,因为只有L型发生选择性乙酰化作用。
因此,本发明还涉及使用抗性基因选择性地使外消旋PTC的L型发生N-乙酰化。
因此,本发明的抗性基因编码的PTC乙酰转移酶可用于分离外消旋PTC,例如,使外消旋体经受此酶的乙酰化作用。可使由德国专利2,717,440的方法所得到的外消旋PTC成为光学对映体,因为此酶只选择性地攻击L型,而D型则保持不变。然后,根据二者性质的差别,通过已知方法可将这样得到的混合物分离开。
已公开了这样一种方法:使N-酰基-D,L-氨基酸与固定在适当载体上的酰基转移酶接触,选择性地释放L-氨基酸,它可以在酸化以后用不与水混溶的溶剂从与N-酰基-D-氨基酸的混合物中萃取出来(见英国专利1,369,462号)。已经公开了N-酰基-D,L-PTC的相应的分离方法,如见于德国专利公开2,939,269号或美国专利4,226,941号。
根据本发明保持不变的D-PTC可通过已知方法外消旋(见公开号为EP-A-0,137,371的欧洲专利申请,实例8),然后回到流程中。
有可能但并不一定要分离出酶,这里及下文中所说的“酶”总是意指具有酶促活性的部分。如果酶被分离出来,它可以以游离形式或在载体上的固定化形式使用。合适载体的例子已在欧洲专利-A0,141,223号中描述了。但方便的作法是不分离酶,而是使用任何预期可表达本发明之酶的PTC抗性细胞。因此,有可能方便地使用绿色产色链霉菌DSM4112的PTT抗性选择体。而且,有可能有利地使用任何用本发明之基因转化的预期细胞,并使之能够表达PTC乙酰转移酶。就此而论,本发明的基因(也是指其活性部分)可以以质粒整合形式或利用其它常规的基因操作方法,例如通过转染引入到宿主细胞中。例如,掺入大肠杆菌的表达质粒中并用这样的质粒转化大肠杆菌是方便可行的,例如可通过欧洲专利-A0,163,249号和0,171,024号中介绍的已知方法进行。
对于外消旋体中的L-PTC的N-乙酰化,根据本发明,可以游离或固定化形式使用表达PTC乙酰转移酶的细胞,使用常规的固定化技术进行固定(例如德国专利公开3,237,341及其中引用的文献)。
本发明中L-PTC的酶促乙酰化以常规的酶促反应方式进行,方法中的条件由所用生物的性质来确定。从原则上讲,适用于此的方法与上述选择性脱酰作用的方法相同。
下述实例进一步阐明了本发明。除非特别指出者外,其中的份数和百分数数据均是指重量。
实例1 PTT抗性选择体
在基本培养基中(Hopwood等人,《链霉菌的基因操作:实验室手册》,The John Innes Foundation Norwieh,England,p.233,1985)培养绿色产色链霉菌DSM4112菌株,加入渐增浓度的PTT。在100μg/ml的浓度下,大约在每10个菌落中发现一个抗性菌落。
实例2载体的制备
用BglⅡ切割质粒pSVHⅠ(欧洲专利0,070,522号,美国专利4,673,642号),分离大小约7.1Kb的片段并与1.1Kb具有硫链丝菌素抗性的BglⅠ片段连接(欧洲专利申请,公开号0,158,201)。得到大小约为8.15Kb的质粒pEB2(图2)。
实例3抗性基因的分离
从实例1得到的选择体中分离总DNA,并用BamHⅠ酶切。同样用BamHⅠ打开质粒pEB2,使两种混合物结合并连接。将连接混合物转化到并铅青链霉菌TK23(可从The John Innes Foundation得到)中,每1微克连接混合物得到5000至10000个具有大约1~5Kb插入段的转化体。选择PTT抗性产生两个具抗性的变铅青链霉菌菌落。从抗性菌落中分离出质粒并用BamHⅠ酶切。发现一个携有负责抗性的基因的4Kb BamHⅠ片段。此质粒被称为pPRⅠ(图3)。
将其再转化到变铅青链霉菌TK23中,证明PTT抗性是由质粒编码的,因为转化体能在含有100μg/mlPTT的基体培养上生长。
实例4证明N-乙酰化使PTC失活
检查下列菌株以证实克隆片段的乙酰化活性:绿色产色链霉菌DSM40736,绿色产色链霉菌(PTT抗性突变株)、变铅青链霉菌TK23和变铅青链霉菌TK23(pPRⅠ)。
这需将菌株接种到溶解培养基A(欧洲专利申请,公开号0,158,872第6页)中,并在轨道式震荡培养器中于30℃保温2天。收获细胞后,取1mg菌丝体在合适的缓冲液(如RS缓冲液:C.J.Thompson等人,J.Bacteriol 151∶678-685,1982)中用超声波破碎。测定PTC降解的典型试验程序如下:
在250μl粗提物中,加入100μl PTC溶液(250μg/ml)和50μl乙酰辅酶A(4mg/ml),将混合物于30℃下保温2小时。此时间过后,用HPLC测定仍然存在的PTC量。此实验基结果如下:
未反应的PTC
菌株
加入的PTC
变铅青链霉菌TK23 100%
绿色产色链霉菌(DSM40736) 72%
绿色产色链霉菌选择体 7%
变铅青链霉菌TK23(pPRⅠ) 31%
在薄层层析上(没有茚三酮显色)与参考物质相比表明,已经发生了PTC的N-乙酰化。
Claims (2)
1、一种获得Phosphinothricin(PTC)抗性基因的方法,该方法包括选择抗2-氨基-4-甲膦酰-丙氨酰-丙氨酸(PTT)的绿色产色链霉菌(Streptomyces viridochromogenes)D SM4112,从抗性菌株中分离总DNA并用BamHI酶切之,分离大小为4.0Kb的片段,以含有抗性基因的完整或亚片段形式克隆此片段并选择PTT抗性。
2、根据权利要求1的方法,其中被克隆的是位于4.0Kb BamHⅠ片段中的0.8Kb BglⅡ片段。
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863628747 DE3628747A1 (de) | 1986-08-23 | 1986-08-23 | Resistenzgen gegen phosphinothricin und seine verwendung |
DEP3628747.4 | 1986-08-23 | ||
DEP3637307.9 | 1986-11-03 | ||
DE3637307 | 1986-11-03 | ||
DE19863642829 DE3642829A1 (de) | 1986-08-23 | 1986-12-16 | Resistenzgen gegen phosphinothricin |
DEP3642829.9 | 1986-12-16 | ||
DEP3700313.5 | 1987-01-08 | ||
DE19873700313 DE3700313A1 (de) | 1986-08-23 | 1987-01-08 | Verwendung eines resistenzgens gegen phosphinothricin |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98115017A Division CN1124347C (zh) | 1986-08-23 | 1998-06-19 | 2-氨基-4-甲膦酰丁酸抗性基因 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN87105764A true CN87105764A (zh) | 1988-11-30 |
CN1040772C CN1040772C (zh) | 1998-11-18 |
Family
ID=27433686
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN87105764A Expired - Lifetime CN1040772C (zh) | 1986-08-23 | 1987-08-22 | 获得2-氨基-4-甲膦酰丁酸基因的方法 |
CN98115017A Expired - Lifetime CN1124347C (zh) | 1986-08-23 | 1998-06-19 | 2-氨基-4-甲膦酰丁酸抗性基因 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98115017A Expired - Lifetime CN1124347C (zh) | 1986-08-23 | 1998-06-19 | 2-氨基-4-甲膦酰丁酸抗性基因 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0257542B1 (zh) |
JP (4) | JPH0797994B2 (zh) |
CN (2) | CN1040772C (zh) |
AT (1) | ATE75776T1 (zh) |
AU (1) | AU604743B2 (zh) |
CA (1) | CA1337597C (zh) |
DK (1) | DK175254B1 (zh) |
ES (1) | ES2038631T3 (zh) |
FI (1) | FI100251B (zh) |
GR (1) | GR3005200T3 (zh) |
HU (1) | HU217208B (zh) |
IL (1) | IL83604A (zh) |
NZ (1) | NZ221526A (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0242236B2 (en) * | 1986-03-11 | 1996-08-21 | Plant Genetic Systems N.V. | Plant cells resistant to glutamine synthetase inhibitors, made by genetic engineering |
CN87100603A (zh) * | 1987-01-21 | 1988-08-10 | 昂科公司 | 抗黑素瘤疫苗 |
DE3716309A1 (de) * | 1987-05-15 | 1988-11-24 | Hoechst Ag | Resistenzgen gegen phosphinothricin |
DE3732972A1 (de) * | 1987-07-02 | 1989-01-12 | Hoechst Ag | Resistenzgen gegen phosphinothricin und seine verwendung |
DE4126414A1 (de) * | 1991-08-09 | 1993-02-11 | Hoechst Ag | Deacetylasegene zur erzeugung von phosphinothricin oder phosphinothricyl-alanyl-alanin, verfahren zu ihrer isolierung und ihre verwendung |
DE4222407C1 (de) * | 1992-07-08 | 1993-10-07 | Max Planck Gesellschaft | Modulartiges Promotor-Konstrukt |
US6586367B2 (en) | 1996-09-05 | 2003-07-01 | Syngenta Crop Protection, Inc. | Process for the control of weeds |
AR008158A1 (es) * | 1996-09-05 | 1999-12-09 | Syngenta Participations Ag | Proceso para el control de malas hierbas en cultivos de plantas utiles que son resistentes a un fosfo-herbicida y una composicion herbicida para dicho uso. |
DE19836700A1 (de) | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Getreidekulturen |
DK1104243T3 (da) | 1998-08-13 | 2013-06-17 | Bayer Cropscience Ag | Herbicide midler til tolerante eller resistente majskulturer |
DE19836684A1 (de) | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Reiskulturen |
DE19836660A1 (de) | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Sojakulturen |
DE19836659A1 (de) | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Baumwollkulturen |
MXPA04007931A (es) | 2002-02-26 | 2004-11-26 | Syngenta Ltd | Metodos para producir selectivamente plantas esteriles masculinas o femeninas. |
CA2586241C (en) | 2004-11-17 | 2013-07-30 | Hokko Chemical Industry Co., Ltd. | Herbicide-resistance gene and utilization thereof |
KR100743611B1 (ko) * | 2006-03-28 | 2007-08-01 | 최광술 | 산업용 로봇의 케이블 조절장치 |
AR074941A1 (es) | 2009-01-07 | 2011-02-23 | Bayer Cropscience Sa | Plantas transplastomicas exentas de marcador de seleccion |
EP2516633B1 (en) | 2009-12-23 | 2017-11-15 | Bayer Intellectual Property GmbH | Plants tolerant to hppd inhibitor herbicides |
AR079882A1 (es) | 2009-12-23 | 2012-02-29 | Bayer Cropscience Ag | Plantas tolerantes a herbicidas inhibidores de las hppd |
EA201290559A1 (ru) | 2009-12-23 | 2013-01-30 | Байер Интеллектуэль Проперти Гмбх | Растения, устойчивые к гербицидам - ингибиторам hppd |
BR112012015692A2 (pt) | 2009-12-23 | 2015-08-25 | Bayer Intelectual Property Gmbh | Plantas tolerantes a herbicida inibidor de hppds. |
UY33139A (es) | 2009-12-23 | 2011-07-29 | Bayer Cropscience Ag | Plantas tolerantes a herbicidas inhibidores de las hppd |
EP2571366A1 (de) | 2010-05-21 | 2013-03-27 | Bayer Intellectual Property GmbH | Herbizide mittel für tolerante oder resistente maiskulturen |
CN103002743A (zh) | 2010-05-21 | 2013-03-27 | 拜耳知识产权有限责任公司 | 用于耐药性或抗药性油菜作物的除草剂 |
WO2011144684A1 (de) | 2010-05-21 | 2011-11-24 | Bayer Cropscience Ag | Herbizide mittel für tolerante oder resistente reiskulturen |
CA2799692A1 (en) | 2010-05-21 | 2011-11-24 | Bayer Intellectual Property Gmbh | Herbicidal agents for tolerant or resistant grain cultures |
EA201390077A1 (ru) | 2010-07-08 | 2013-06-28 | Байер Кропсайенс Нв | Белок-переносчик глюкозинолатов и его применения |
WO2012101118A1 (en) | 2011-01-24 | 2012-08-02 | Bayer Cropscience N.V. | Use of the rd29 promoter or fragments thereof for stress-inducible expression of transgenes in cotton |
EP2524602A1 (de) | 2011-05-20 | 2012-11-21 | Bayer CropScience AG | Herbizide Mittel für tolerante oder resistente Sojakulturen |
UA117816C2 (uk) | 2012-11-06 | 2018-10-10 | Байєр Кропсайєнс Акцієнгезелльшафт | Гербіцидна комбінація для толерантних соєвих культур |
DE202014101590U1 (de) | 2014-04-03 | 2014-04-29 | Igus Gmbh | Führungssystem für Versorgungsleitungen und Roboter mit Führungssystem |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0242236B2 (en) * | 1986-03-11 | 1996-08-21 | Plant Genetic Systems N.V. | Plant cells resistant to glutamine synthetase inhibitors, made by genetic engineering |
-
1987
- 1987-08-19 AT AT87112023T patent/ATE75776T1/de not_active IP Right Cessation
- 1987-08-19 ES ES198787112023T patent/ES2038631T3/es not_active Expired - Lifetime
- 1987-08-19 EP EP87112023A patent/EP0257542B1/de not_active Expired - Lifetime
- 1987-08-20 FI FI873610A patent/FI100251B/fi not_active IP Right Cessation
- 1987-08-21 CA CA000545037A patent/CA1337597C/en not_active Expired - Lifetime
- 1987-08-21 IL IL8360487A patent/IL83604A/en not_active IP Right Cessation
- 1987-08-21 DK DK198704378A patent/DK175254B1/da not_active IP Right Cessation
- 1987-08-21 NZ NZ221526A patent/NZ221526A/xx unknown
- 1987-08-21 AU AU77318/87A patent/AU604743B2/en not_active Expired
- 1987-08-22 JP JP62209123A patent/JPH0797994B2/ja not_active Expired - Lifetime
- 1987-08-22 CN CN87105764A patent/CN1040772C/zh not_active Expired - Lifetime
- 1987-08-23 HU HU727/87A patent/HU217208B/hu unknown
-
1990
- 1990-02-28 JP JP2049140A patent/JP2749424B2/ja not_active Expired - Lifetime
-
1992
- 1992-07-16 GR GR920401371T patent/GR3005200T3/el unknown
-
1994
- 1994-10-14 JP JP6249627A patent/JPH07147985A/ja active Pending
-
1996
- 1996-10-09 JP JP8268910A patent/JP2815847B2/ja not_active Expired - Lifetime
-
1998
- 1998-06-19 CN CN98115017A patent/CN1124347C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH03103193A (ja) | 1991-04-30 |
CN1124347C (zh) | 2003-10-15 |
JP2815847B2 (ja) | 1998-10-27 |
EP0257542B1 (de) | 1992-05-06 |
FI873610A0 (fi) | 1987-08-20 |
IL83604A (en) | 2004-02-19 |
JP2749424B2 (ja) | 1998-05-13 |
JPS6371183A (ja) | 1988-03-31 |
DK437887A (da) | 1988-02-24 |
HUT44621A (en) | 1988-03-28 |
DK175254B1 (da) | 2004-07-26 |
EP0257542A3 (en) | 1990-03-07 |
HU217208B (hu) | 1999-12-28 |
CA1337597C (en) | 1995-11-21 |
JPH09107981A (ja) | 1997-04-28 |
CN1040772C (zh) | 1998-11-18 |
IL83604A0 (en) | 1988-01-31 |
GR3005200T3 (zh) | 1993-05-24 |
FI100251B (fi) | 1997-10-31 |
ES2038631T3 (es) | 1993-08-01 |
DK437887D0 (da) | 1987-08-21 |
JPH0797994B2 (ja) | 1995-10-25 |
EP0257542A2 (de) | 1988-03-02 |
NZ221526A (en) | 1989-03-29 |
AU7731887A (en) | 1988-05-19 |
JPH07147985A (ja) | 1995-06-13 |
AU604743B2 (en) | 1991-01-03 |
ATE75776T1 (de) | 1992-05-15 |
FI873610A (fi) | 1988-02-24 |
CN1225393A (zh) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN87105764A (zh) | 2-氨基-4-甲膦酰丁酸抗性基因及其应用 | |
US5273894A (en) | Phosphinothricin-resistance gene, and its use | |
US5637489A (en) | Phosphinothricin-resistance gene, and its use | |
CA1188236A (en) | Plasmids | |
Dron et al. | Glutathione and fungal elicitor regulation of a plant defense gene promoter in electroporated protoplasts | |
McGowan et al. | Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel β‐lactam resistance mechanism | |
JP2674998B2 (ja) | 抗生物質産生微生物の改良 | |
Rossbach et al. | Molecular and genetic characterization of the rhizopine catabolism (mocABRC) genes of Rhizobium meliloti L5-30 | |
KR20090013814A (ko) | 이소프레노이드의 생산 방법 | |
CA1185547A (en) | Plasmid pel 7 and related cloning vectors for use in streptomyces and related organisms | |
CN107058370A (zh) | 蛋白质表达或阻抑的系统、方法和设备 | |
McEWEN et al. | Genetic analysis of Escherichia coli K-12 chromosomal mutants defective in expression of F-plasmid functions: identification of genes cpxA and cpxB | |
Webera et al. | Identification of a gene required for the terminal step in erythromycin A biosynthesis in Saccharopolyspora erythraea (Streptomyces erythreus) | |
Friesen et al. | Nonsense and insertion mutants in the relA gene of E. coli: cloning relA | |
FI111552B (fi) | Menetelmä rekombinanttisen isäntäsolukannan tuottamiseksi ja näin saatu rekombinanttinen isäntäsolu | |
Aguilar et al. | The product of the Rhizobium meliloti ilvC gene is required for isoleucine and valine synthesis and nodulation of alfalfa | |
CN111117942A (zh) | 一种产林可霉素的基因工程菌及其构建方法和应用 | |
US20120015404A1 (en) | Gene cluster for thuringiensin synthesis | |
EP0089233A2 (en) | Plasmid pSAN 81 and a process for its extraction from a cell culture | |
US5183759A (en) | Recombinant Rhizobium bacteria inoculants | |
Ling et al. | sanN encoding a dehydrogenase is essential for nikkomycin biosynthesis in Streptomyces ansochromogenes | |
CA2017783A1 (en) | Recombinant rhizobium bacteria inoculants | |
EP0038156A2 (en) | A plasmid and its microbiological preparation | |
JPH10262670A (ja) | ビフィズス菌用シャトルベクター及びビフィズス菌プラスミドの複製タンパク質遺伝子 | |
GB2045251A (en) | A plasmid and its microbiological preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
C17 | Cessation of patent right |